Fintel reports that on November 6, 2024, Raymond James upgraded their outlook for Masimo (NasdaqGS:MASI) from Market Perform ...

Masimo (NASDAQ: MASI) today announced that its management will participate in the Jefferies London Healthcare Conference on Thursday, November 21, 2024 at 8:30 a.m. GMT. A live webcast of the ...

Masimo delivered Q3 results that mostly aligned with guidance, yet it faces challenges in its non-healthcare segment.

Apple and Masimo are back in a California court this week for a bench ... the two companies in which the former alleges the latter unlawfully incorporated its pulse oximetry tech into the Apple Watch.

The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of ...

Medtronic settled a lawsuit claiming its pulse oximeters may provide less accurate readings for people with darker skin pigmentation. Medtronic agreed to provide labels and brochures to California ...

Masimo SET ® Measure-through Motion and Low Perfusion™ pulse oximetry, introduced in 1995, has been shown in over 100 independent and objective studies to outperform other pulse oximetry ...

Piper Sandler named Masimo Corporation (NASDAQ:MASI) as a new top idea on Friday, noting that the pulse oximetry company will soon reach a significant reset in its margins and earnings ...

The modular, scalable monitoring platform offers a range of physiological measurements, including Masimo SET ® pulse oximetry ... innovative measurements, sensors, patient monitors, and ...

Apple's legal team argued that Masimo had copied the Apple Watch's design and functionality, focusing on the device's aesthetic appeal rather than its innovative pulse oximetry technology.